First Trust Amex Biotech Index Fund (NY:FBT)
268.32
-2.63
(-0.97%)
Streaming Delayed Price
Updated: 12:39 PM EDT, Aug 24, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 110,116 |
| Open | 269.17 |
| Bid (Size) | 267.92 (100) |
| Ask (Size) | 268.12 (600) |
| Prev. Close | 270.95 |
| Today's Range | 267.28 - 269.70 |
| 52wk Range | 171.00 - 272.80 |
| Shares Outstanding | 62,000 |
| Dividend Yield | 0.44% |
Top News
More News
Performance
More News
Read More
Why Did SRPT Stock Rise 6% In Pre-Market Today? ↗
January 26, 2026
POET Technologies Lands $5 Million Order As AI Demand Surges ↗
October 22, 2025
Healthcare Sector Trying To Bounce Back ↗
March 09, 2025
US Judge Weighs Nationwide Ban On Abortion Pills ↗
March 16, 2023
Frequently Asked Questions
Is First Trust Amex Biotech Index Fund publicly traded?
Yes, First Trust Amex Biotech Index Fund is publicly traded.
What exchange does First Trust Amex Biotech Index Fund trade on?
First Trust Amex Biotech Index Fund trades on the New York Stock Exchange
What is the ticker symbol for First Trust Amex Biotech Index Fund?
The ticker symbol for First Trust Amex Biotech Index Fund is FBT on the New York Stock Exchange
What is the current price of First Trust Amex Biotech Index Fund?
The current price of First Trust Amex Biotech Index Fund is 268.32
When was First Trust Amex Biotech Index Fund last traded?
The last trade of First Trust Amex Biotech Index Fund was at 08/24/26 12:39 PM ET
What is the market capitalization of First Trust Amex Biotech Index Fund?
The market capitalization of First Trust Amex Biotech Index Fund is 16.64M
How many shares of First Trust Amex Biotech Index Fund are outstanding?
First Trust Amex Biotech Index Fund has 17M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.